ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:ICLR
- CUSIP: N/A
- Web: www.iconplc.com
Capitalization:- Market Cap: $5.68457 billion
- Outstanding Shares: 54,041,000
Average Prices:- 50 Day Moving Avg: $101.46
- 200 Day Moving Avg: $89.84
- 52 Week Range: $73.76 - $109.32
P/E:- Trailing P/E Ratio: 21.30
- Foreward P/E Ratio: 17.76
- P/E Growth: 1.36
Sales & Book Value:- Annual Revenue: $1.72 billion
- Price / Sales: 3.30
- Book Value: $19.05 per share
- Price / Book: 5.51
Profitability:- EBIDTA: $393.57 million
- Net Margins: 15.97%
- Return on Equity: 28.72%
- Return on Assets: 15.01%
Debt:- Debt-to-Equity Ratio: 0.34%
- Current Ratio: 2.11%
- Quick Ratio: 2.11%
Misc:- Average Volume: 347,930 shs.
- Beta: 0.6
- Short Ratio: 3.49
Frequently Asked Questions for Icon Plc (NASDAQ:ICLR)
What is Icon Plc's stock symbol?
Icon Plc trades on the NASDAQ under the ticker symbol "ICLR."
How were Icon Plc's earnings last quarter?
Icon Plc (NASDAQ:ICLR) posted its quarterly earnings data on Thursday, July, 27th. The company reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.30 by $0.01. The business earned $431 million during the quarter, compared to the consensus estimate of $430.68 million. Icon Plc had a net margin of 15.97% and a return on equity of 28.72%. Icon Plc's quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 EPS. View Icon Plc's Earnings History.
When will Icon Plc make its next earnings announcement?
What guidance has Icon Plc issued on next quarter's earnings?
Icon Plc updated its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $5.18-5.36 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.18. The company issued revenue guidance of $1.74-1.77 billion, compared to the consensus revenue estimate of $1.72 billion.
Where is Icon Plc's stock going? Where will Icon Plc's stock price be in 2017?
9 equities research analysts have issued 1-year target prices for Icon Plc's stock. Their forecasts range from $92.00 to $126.00. On average, they anticipate Icon Plc's stock price to reach $108.43 in the next year. View Analyst Ratings for Icon Plc.
Who are some of Icon Plc's key competitors?
Some companies that are related to Icon Plc include Alkermes PLC (ALKS), Alnylam Pharmaceuticals (ALNY), Qiagen N.V. (QGEN), Seattle Genetics (SGEN), Ionis Pharmaceuticals (IONS), United Therapeutics Corporation (UTHR), Charles River Laboratories International (CRL), PRA Health Sciences (PRAH), PAREXEL International Corporation (PRXL), Exact Sciences Corporation (EXAS), Galapagos NV (GLPG), Bio-Techne Corp (TECH), ACADIA Pharmaceuticals (ACAD), WuXi PharmaTech (Cayman) (WX), FibroGen (FGEN), Portola Pharmaceuticals (PTLA), Sage Therapeutics (SAGE) and INC Research Holdings (INCR).
Who are Icon Plc's key executives?
Icon Plc's management team includes the folowing people:
- Ciaran Murray, Chairman of the Board
- Steve Cutler, Chief Executive Officer, Director
- Brendan Brennan, Chief Financial Officer
- Diarmaid Cunningham, Executive Vice President, General Counsel, Secretary
- Hugh Brady, Non-Executive Director
- John Climax, Non-Executive Director
- William W. Hall M.D., Ph.D., Non-Executive Director
- Ronan Lambe Ph.D., Non-Executive Director
- Mary K. Pendergast J.D., Non-Executive Director
Who owns Icon Plc stock?
Icon Plc's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include WCM Investment Management CA (7.34%), Earnest Partners LLC (5.16%), Alliancebernstein L.P. (5.07%), FMR LLC (4.24%), Acadian Asset Management LLC (4.07%) and Wasatch Advisors Inc. (3.42%). View Institutional Ownership Trends for Icon Plc.
Who sold Icon Plc stock? Who is selling Icon Plc stock?
Icon Plc's stock was sold by a variety of institutional investors in the last quarter, including Earnest Partners LLC, Neuberger Berman Group LLC, Alliancebernstein L.P., Balyasny Asset Management LLC, Westfield Capital Management Co. LP, Kennedy Capital Management Inc., Arrowstreet Capital Limited Partnership and Peregrine Capital Management LLC. View Insider Buying and Selling for Icon Plc.
Who bought Icon Plc stock? Who is buying Icon Plc stock?
Icon Plc's stock was bought by a variety of institutional investors in the last quarter, including Koch Industries Inc., FMR LLC, Janus Henderson Group PLC, Mckinley Capital Management LLC Delaware, WCM Investment Management CA, Systematic Financial Management LP, Renaissance Technologies LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for Icon Plc.
How do I buy Icon Plc stock?
Shares of Icon Plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Icon Plc's stock price today?
One share of Icon Plc stock can currently be purchased for approximately $104.99.
MarketBeat Community Rating for Icon Plc (NASDAQ ICLR)MarketBeat's community ratings are surveys of what our community members think about Icon Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Icon Plc (NASDAQ:ICLR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating |
| Consensus Rating: | Buy (Score: 2.89) |
| Consensus Price Target: | $108.43 (3.28% upside) |
Analysts' Ratings History for Icon Plc (NASDAQ:ICLR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/31/2017 | KeyCorp | Reiterated Rating | Overweight | | Medium |  |
| 7/31/2017 | SunTrust Banks, Inc. | Upgrade | Hold -> Buy | $93.00 -> $126.00 | Medium | |
| 7/30/2017 | Jefferies Group LLC | Reiterated Rating | Buy | | Medium | |
| 7/28/2017 | Credit Suisse Group | Reiterated Rating | Buy | | Low | |
| 7/27/2017 | Mizuho | Boost Price Target | Neutral -> Neutral | $104.00 -> $108.00 | Low | |
| 7/7/2017 | Goldman Sachs Group, Inc. (The) | Upgrade | Buy -> Conviction-Buy | $117.00 | High | |
| 6/9/2017 | Robert W. Baird | Lower Price Target | Outperform | $107.00 -> $97.00 | Low | |
| 4/28/2017 | Evercore ISI | Boost Price Target | Outperform | $91.50 -> $92.00 | Low | |
| 10/20/2016 | Avondale Partners | Upgrade | Underperform -> Market Perform | | N/A | |
(Data available from 8/19/2015 forward)
Earnings History for Icon Plc (NASDAQ:ICLR)Earnings History by Quarter for Icon Plc (NASDAQ ICLR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/18/2017 | | $1.28 | | | | | N/A | |
| 7/27/2017 | 6/30/2017 | $1.30 | $1.31 | $430.68 million | $431.00 million | View | N/A | |
| 4/27/2017 | 3/31/2017 | $1.27 | $1.29 | $432.21 million | $432.00 million | View | N/A | |
| 2/16/2017 | Q416 | $1.26 | $1.33 | $440.78 million | $435.00 million | View | Listen | |
| 10/20/2016 | Q316 | $1.18 | $1.19 | $420.14 million | $420.20 million | View | Listen | |
| 7/26/2016 | Q216 | $1.14 | $1.14 | $409.97 million | $411.00 million | View | Listen | |
| 4/26/2016 | Q116 | $1.11 | $1.12 | $414.35 million | $400.50 million | View | Listen | |
| 2/23/2016 | Q415 | $1.10 | $1.11 | $409.42 million | $403.00 million | View | Listen | |
| 10/27/2015 | Q315 | $1.01 | $1.02 | $399.02 million | $394.70 million | View | Listen | |
| 7/28/2015 | Q215 | $0.90 | $0.95 | $402.15 million | $389.00 million | View | Listen | |
| 4/28/2015 | Q115 | $0.81 | $0.90 | $391.11 million | $388.00 million | View | N/A | |
| 2/25/2015 | Q4 | $0.76 | $0.87 | $391.37 million | $390.10 million | View | N/A | |
| 10/22/2014 | Q314 | $0.70 | $0.79 | $391.12 million | $388.00 million | View | Listen | |
| 7/30/2014 | Q2 | $0.58 | $0.64 | $376.89 million | $376.00 million | View | Listen | |
| 4/30/2014 | Q1 | $0.50 | $0.57 | $352.14 million | $350.00 million | View | Listen | |
| 2/20/2014 | Q413 | $0.45 | $0.53 | $339.86 million | $345.00 million | View | Listen | |
| 10/24/2013 | Q313 | $0.41 | $0.45 | $332.58 million | $339.80 million | View | Listen | |
| 7/25/2013 | Q2 2013 | $0.38 | $0.43 | $321.82 million | $334.20 million | View | Listen | |
| 4/25/2013 | Q1 2013 | $0.34 | $0.36 | $300.81 million | $317.00 million | View | Listen | |
| 2/19/2013 | Q4 2012 | $0.33 | $0.34 | $291.96 million | $300.00 million | View | Listen | |
| 11/1/2012 | Q312 | $0.27 | $0.29 | $282.67 million | $286.00 million | View | N/A | |
| 7/24/2012 | | $0.22 | $0.21 | | | View | N/A | |
| 4/24/2012 | | $0.15 | $0.15 | | | View | N/A | |
| 2/16/2012 | | $0.08 | $0.07 | | | View | N/A | |
| 10/27/2011 | | $0.02 | $0.02 | | | View | N/A | |
| 7/20/2011 | | $0.22 | $0.21 | | | View | N/A | |
| 4/21/2011 | | $0.21 | $0.21 | | | View | N/A | |
| 2/24/2011 | | $0.36 | $0.36 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Icon Plc (NASDAQ:ICLR)2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.80
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $1.22 | $1.34 | $1.27 |
| Q2 2017 | 5 | $1.26 | $1.35 | $1.30 |
| Q3 2017 | 5 | $1.27 | $1.37 | $1.31 |
| Q4 2017 | 5 | $1.38 | $1.41 | $1.40 |
| Q1 2018 | 2 | $1.35 | $1.38 | $1.37 |
| Q2 2018 | 2 | $1.43 | $1.45 | $1.44 |
| Q3 2018 | 1 | $1.46 | $1.46 | $1.46 |
| Q4 2018 | 1 | $1.53 | $1.53 | $1.53 |
(Data provided by Zacks Investment Research)
Dividend History for Icon Plc (NASDAQ:ICLR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Icon Plc (NASDAQ:ICLR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Icon Plc (NASDAQ:ICLR)
Latest Headlines for Icon Plc (NASDAQ:ICLR)
| Source: |
|
| Date | Headline |
|---|
 | Icon Plc (ICLR) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - August 19 at 12:38 AM |
| Head-To-Head Contrast: ICON PLC (ICLR) & Cleveland BioLabs (CBLI)
www.americanbankingnews.com - August 18 at 6:22 AM |
| Icon Plc (NASDAQ:ICLR) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - August 12 at 12:44 AM |
 | See what the IHS Markit Score report has to say about ICON PLC.
finance.yahoo.com - August 11 at 8:14 PM |
| ICON plc :ICLR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017
finance.yahoo.com - August 11 at 3:26 AM |
| Zacks: Brokerages Expect Icon Plc (NASDAQ:ICLR) Will Post Earnings of $1.31 Per Share
www.americanbankingnews.com - August 8 at 2:28 PM |
| Icon Plc Forecasted to Post Q4 2017 Earnings of $1.41 Per Share (ICLR)
www.americanbankingnews.com - August 3 at 12:52 PM |
| Corporate News Blog - LabCorp to Buy Chiltern for $1.2 Billion in Cash; Advancing Its Leadership in Drug Development
finance.yahoo.com - August 2 at 10:48 PM |
| Q3 2017 EPS Estimates for ICON PLC Raised by First Analysis (NASDAQ:ICLR)
www.americanbankingnews.com - August 2 at 7:02 AM |
| ICON PLC to Post Q3 2017 Earnings of $1.30 Per Share, SunTrust Banks Forecasts (NASDAQ:ICLR)
www.americanbankingnews.com - August 1 at 7:41 AM |
| ICON PLC Forecasted to Earn Q3 2017 Earnings of $1.37 Per Share (ICLR)
www.americanbankingnews.com - August 1 at 7:41 AM |
| LabCorp just signed a billion-dollar deal for a healthcare company you've probably never heard of
finance.yahoo.com - July 31 at 7:09 PM |
| Icon Plc to Post Q3 2017 Earnings of $1.30 Per Share, Jefferies Group Forecasts (NASDAQ:ICLR)
www.americanbankingnews.com - July 31 at 7:45 AM |
| William Blair Analysts Lift Earnings Estimates for Icon Plc (ICLR)
www.americanbankingnews.com - July 31 at 7:45 AM |
| Jefferies Group LLC Reiterates "Buy" Rating for ICON PLC (NASDAQ:ICLR)
www.americanbankingnews.com - July 30 at 11:18 AM |
 | ICON plc (ICLR) Acquires Mapi Group
www.streetinsider.com - July 28 at 10:57 PM |
| ICON PLC (NASDAQ:ICLR) Rating Reiterated by Credit Suisse Group
www.americanbankingnews.com - July 28 at 4:39 PM |
| Icon Plc (ICLR) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 28 at 12:20 AM |
| ICON Reports Second Quarter 2017 Results
finance.yahoo.com - July 27 at 10:16 PM |
| ICON Acquires Mapi Group
finance.yahoo.com - July 27 at 10:16 PM |
| Icon PLC tops Street 2Q forecasts
finance.yahoo.com - July 27 at 10:16 PM |
| Edited Transcript of ICLR earnings conference call or presentation 27-Jul-17 1:00pm GMT
finance.yahoo.com - July 27 at 10:16 PM |
| Icon Plc (ICLR) Issues FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 12:14 PM |
| ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
finance.yahoo.com - July 26 at 4:12 PM |
| Icon Plc (ICLR) Expected to Post Quarterly Sales of $429.66 Million
www.americanbankingnews.com - July 21 at 7:17 PM |
| Wall Street is making huge bets on healthcare companies you've never heard of
finance.yahoo.com - July 20 at 11:25 PM |
| Brokerages Anticipate Icon Plc (ICLR) Will Announce Earnings of $1.30 Per Share
www.americanbankingnews.com - July 19 at 9:15 AM |
| Icon Plc (ICLR) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 18 at 12:48 AM |
 | Undervalued R&D Leader With Great Risk/Reward
seekingalpha.com - July 10 at 7:41 PM |
| Icon Leads The Pack In ROIC, Looks Like Good Value
finance.yahoo.com - July 10 at 7:40 PM |
| ICON Shares Added To Goldman's 'Conviction Buy' List
finance.yahoo.com - July 8 at 11:39 AM |
| Icon Plc (NASDAQ:ICLR) Raised to "Conviction-Buy" at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - July 7 at 8:44 AM |
| ICON wins eLearning and Animation Awards for its FIRECREST Digital Solutions
finance.yahoo.com - July 6 at 5:02 AM |
| ICON PLC Expected to Earn FY2018 Earnings of $5.55 Per Share (ICLR)
www.americanbankingnews.com - July 3 at 9:41 AM |
| Icon Plc (NASDAQ:ICLR) Short Interest Update
www.americanbankingnews.com - July 1 at 7:14 AM |
| Jefferies Upgrades ICON plc (ICLR) to Buy
www.streetinsider.com - July 1 at 12:53 AM |
| Jefferies Group Weighs in on ICON PLC's FY2017 Earnings (ICLR)
www.americanbankingnews.com - June 30 at 9:13 AM |
| Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research
finance.yahoo.com - June 30 at 12:05 AM |
| Jefferies Group LLC Upgrades Icon Plc (ICLR) to Buy
www.americanbankingnews.com - June 29 at 7:52 AM |
| Icon Plc (ICLR) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - June 27 at 11:28 PM |
| ICON PLC (ICLR) Expected to Post Quarterly Sales of $429.92 Million
www.americanbankingnews.com - June 25 at 11:20 AM |
| Icon Plc (ICLR) Lifted to Buy at BidaskClub
www.americanbankingnews.com - June 23 at 8:20 PM |
| $1.30 Earnings Per Share Expected for Icon Plc (ICLR) This Quarter
www.americanbankingnews.com - June 23 at 8:10 AM |
| Icon Plc (ICLR) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 21 at 12:38 AM |
| [$$] Drug-Research Shake Up Continues as Pamplona Reaches Deal to Buy Parexel
finance.yahoo.com - June 20 at 6:39 PM |
| Icon Plc (ICLR) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - June 16 at 9:58 PM |
| ICON and DIA Amplify Thought Leadership and Debate with DIA Live 2017
finance.yahoo.com - June 16 at 6:39 PM |
 | Healthcare Stocks on Investors' Radar -- PAREXEL, IDEXX Labs, ICON PLC, and PRA Health Sciences
www.nasdaq.com - June 9 at 11:16 PM |
| Icon Plc's (ICLR) Outperform Rating Reiterated at Robert W. Baird
www.americanbankingnews.com - June 9 at 9:32 PM |
| ICON plc (ICLR) PT Raised to $102 at Credit Suisse; Strengthening Fundamentals & Momentum in Biotech Funding
www.streetinsider.com - June 6 at 11:23 PM |
Icon Plc (ICLR) Chart for Saturday, August, 19, 2017
